OBJECTIVE: The disentangling of early sensory information processing deficits and examination of their relationships to demographic and clinical factors are important steps for the validation of potential biomarkers and/or endophenotypes of schizophrenia. The aims of the present study were to characterize commonly used sensory event-related potential deficits, to determine whether they are (1) distinct from one another and (2) independently associated with important clinical characteristics. METHODS: MMN, P3a and RON event-related potentials (ERP) were recorded from schizophrenia patients (SZ; n=429) and nonpsychiatric comparison subjects (NCS; n=286). Subgroup analyses on demographic and clinical variables were performed. RESULTS: Schizophrenia patients exhibited robust ERP deficits at frontocentral electrodes (MMN: d=1.10; P3a: d=0.87; RON: d=0.77), consistent with previous studies. Each ERP component uniquely accounted for variance in amplitude and schizophrenia deficits. Amplitude reductions occurred with increasing age in both NCS and SZ patients. A small subset of patients prescribed combinations of 1st and 2nd generation antipsychotics exhibited significantly reduced MMN amplitude relative to other medication-defined subgroups. CONCLUSIONS: MMN, P3a, and RON are dissociable deficits with distinct relationships to age and medication status in schizophrenia patients, potentially reflecting divergent pathophysiological processes. Reduced MMN in patients taking multiple antipsychotic medications appear to be attributable to greater severity of symptoms and functional impairments, rather than a medication effect. SIGNIFICANCE: Independent information processing deficits in schizophrenia patients may differentially contribute to the commonly observed deficits in neurocognitive and psychosocial functioning. Published by Elsevier Ireland Ltd.
OBJECTIVE: The disentangling of early sensory information processing deficits and examination of their relationships to demographic and clinical factors are important steps for the validation of potential biomarkers and/or endophenotypes of schizophrenia. The aims of the present study were to characterize commonly used sensory event-related potential deficits, to determine whether they are (1) distinct from one another and (2) independently associated with important clinical characteristics. METHODS: MMN, P3a and RONevent-related potentials (ERP) were recorded from schizophreniapatients (SZ; n=429) and nonpsychiatric comparison subjects (NCS; n=286). Subgroup analyses on demographic and clinical variables were performed. RESULTS:Schizophreniapatients exhibited robust ERP deficits at frontocentral electrodes (MMN: d=1.10; P3a: d=0.87; RON: d=0.77), consistent with previous studies. Each ERP component uniquely accounted for variance in amplitude and schizophrenia deficits. Amplitude reductions occurred with increasing age in both NCS and SZ patients. A small subset of patients prescribed combinations of 1st and 2nd generation antipsychotics exhibited significantly reduced MMN amplitude relative to other medication-defined subgroups. CONCLUSIONS: MMN, P3a, and RON are dissociable deficits with distinct relationships to age and medication status in schizophreniapatients, potentially reflecting divergent pathophysiological processes. Reduced MMN in patients taking multiple antipsychotic medications appear to be attributable to greater severity of symptoms and functional impairments, rather than a medication effect. SIGNIFICANCE: Independent information processing deficits in schizophreniapatients may differentially contribute to the commonly observed deficits in neurocognitive and psychosocial functioning. Published by Elsevier Ireland Ltd.
Authors: Ulrich Schall; Stanley V. Catts; Shail Chaturvedi; Barbara Liebert; Joanna Redenbach; Frini Karayanidis; Philip B. Ward Journal: Int J Neuropsychopharmacol Date: 1998-07 Impact factor: 5.176
Authors: Daniel Umbricht; Daniel Javitt; Gerald Novak; John Bates; Simcha Pollack; Jeffrey Lieberman; John Kane Journal: Int J Neuropsychopharmacol Date: 1999-12 Impact factor: 5.176
Authors: Claudia Lainscsek; Aaron L Sampson; Robert Kim; Michael L Thomas; Karen Man; Xenia Lainscsek; Neal R Swerdlow; David L Braff; Terrence J Sejnowski; Gregory A Light Journal: Proc Natl Acad Sci U S A Date: 2019-02-11 Impact factor: 11.205
Authors: Michael Avissar; Shanghong Xie; Blair Vail; Javier Lopez-Calderon; Yuanjia Wang; Daniel C Javitt Journal: Schizophr Res Date: 2017-07-11 Impact factor: 4.939
Authors: Migyung Lee; Andrea Balla; Henry Sershen; Pejman Sehatpour; Peter Lakatos; Daniel C Javitt Journal: Neuropsychopharmacology Date: 2017-08-17 Impact factor: 7.853
Authors: Anthony J Rissling; Sung-Hyouk Park; Jared W Young; Michelle B Rissling; Catherine A Sugar; Joyce Sprock; Daniel J Mathias; Marlena Pela; Richard F Sharp; David L Braff; Gregory A Light Journal: Schizophr Res Date: 2013-03-11 Impact factor: 4.939